Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure

Military Medicine

Volumn 164, Issue 12, 1999, Pages 833-837

  Hail, Alec S ^a   Rossi, Cynthia A ^a   Ludwig, George V ^a   Ivins, Bruce E ^a   Tammariello, Ralph F ^a   Henchal, Ltc Erik A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ANTHRAX; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS ANTHRACIS; COLONY FORMING UNIT; CONTROLLED STUDY; NONHUMAN; RHESUS MONKEY; SAMPLING; VACCINATION;

EID: 0033455620     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/164.12.833     Document Type: Article

References (21)

1. Zilinskas RA: Iraq's biological weapons: the past as future. JAMA 1997; 278: 418-24.
2. Aiello SE, Mays A: The Merck Veterinary Manual, Ed 8, pp 432-5. Whitehouse Station, NJ, Merck & Co, 1998.
3. Benenson AS, Chin J: Control of Communicable Diseases Manual, Ed 16, pp 18-22. Washington, DC, American Public Health Association, 1995.
4. Friedlander AM, Welkos SL, Pitt MLM, Ezzell JW, Worsham PL, Rose KJ, Ivins BE, Lowe JR, Howe GB, Mikesell P, Lawrence WB: Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 1993; 167: 1239-42.
5. Fritz DL, Jaax NK, Lawrence WB, Davis KJ, Pitt MLM, Ezzell JW, Friedlander AM: Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest 1995; 73: 691-702.
6. Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants, pp 72-99. Geneva, Switzerland, World Health Organization, 1970.
7. Franz DR, Jahrling PJ, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM: Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399-411.
8. Kaufmann AF, Meltzer MI, Schmid GP: The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997; 3: 83-94.
9. LaForce FM: Anthrax. Clin Infect Dis 1994; 19: 1009-14.
10. Sidell FR, Takafuji ET, Franz DR, Friedlander AM: Medical Aspects of Chemical and Biological Warfare, pp 467-78. Washington, DC, Office of the Surgeon General, 1997.
11. Steffen R, Melling J, Woodall JP, Rollin PE, Lang RH, Luthy R, Waldvogel A: Preparation for emergency relief after biological warfare. J Infect 1997; 34: 127-32.
12. Holloway HC, Norwood AE, Fullerton CS, Engel CC, Ursano RJ: The threat of biological weapons. JAMA 1997; 278: 425-7.
13. Simon JD: Biological terrorism. JAMA 1997; 278: 428-30.
14. Tucker JB: National health and medical services response to incidents of chemical and biological terrorism. JAMA 1997; 278: 362-8.
15. Stephenson J: Pentagon-funded research takes aim at agents of biological warfare. JAMA 1997; 278: 373-5.
16. Ivins BE, Fellows PF, Pitt MLM, Estep JE, Welkos SL, Worsham PL, Friedlander AM: Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Proceedings of the International Workshop on Anthrax, 19-21 September 1995, Winchester, UK. Salisbury Med Bull 1996; June (special suppl 87): 125-6.
17. Besch TK, Ruble DL, Gibbs PH, Pitt MLM: Steady state minute volume determination by body-only plethysmography in juvenile rhesus monkeys. Lab Anim Sci 1996; 46: 539-44.
18. -) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun 1990; 58: 303-8.
19. Leighton TJ, Doi RH: The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis. J Biol Chem 1971; 246: 3189-95.
20. Carpenter CB, Jaax GP, Agee WJ, Wise EC: A novel ventilated transport container for transporting laboratory animals. Contemp Top Lab Anim Sci 1997; 37: 69-72.
21. Carruthers GB, Parry JM, Turnbull PCB, Gibson JR: A Colour Atlas of Bacillus Species, pp 59-112. London, Wolfe Medical Publications, 1983.